Researchers have found in a recent analysis reveals IL-17 inhibitors significantly increase the risk of Candida infections ...

Interleukin-17 (IL-17) inhibitors demonstrated faster psoriasis (PsO) clearance than Interleukin-23 (IL-23) inhibitors. However, IL-23 inhibitors were often favored due to their safety profile and ...

UCB has been bringing up the rear in the IL-17 inhibitor category with bimekizumab, but now has EU approval for the drug and thinks it can mount a stiff challenge to the leaders, including ...

When focusing specifically on IL-17 and IL-23 inhibitors, women still showed shorter overall and effectiveness-related drug survival, although no significant sex difference was observed for AE ...

IL-17 inhibitors secukinumab and brodalumab demonstrate similar efficacy in patients with psoriasis for up to a year after dose spacing, according to a retrospective cohort study.

This study is the first randomized, double-blind, controlled Phase 3 clinical study evaluating biologics switching in psoriasis patients with prior inadequate response to anti-IL-17 antibody.

Prior exposure to biologics was associated with a decline in survival, with significantly larger reductions observed for IL-17 inhibitors. IN PRACTICE: "Drug survival is high with IL23p19 inhibitors.

IL-17A, commonly referred to as IL-17, is the founding member of the IL-17 family, which consists of six ligands, A–F. IL-17F shares 50% sequence homology with IL-17A and has similar but less ...

UCB has been bringing up the rear in the IL-17 inhibitor category with bimekizumab, but now has EU approval for the drug and thinks it can mount a stiff challenge to the leaders, including ...

This study is the first randomized, double-blind, controlled Phase 3 clinical study evaluating biologics switching in psoriasis patients with prior inadequate response to anti-IL-17 antibody.

SAN FRANCISCO and SUZHOU, China, May 28, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and ...